Teladoc Health (NYSE:TDOC) Given “Hold” Rating at Needham & Company LLC

Needham & Company LLC reissued their hold rating on shares of Teladoc Health (NYSE:TDOC) in a research note released on Thursday,Benzinga reports.

A number of other equities analysts have also recently issued reports on TDOC. Jefferies Financial Group dropped their price objective on Teladoc Health from $10.00 to $8.00 and set a “hold” rating for the company in a report on Monday, April 21st. Royal Bank of Canada upped their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Piper Sandler decreased their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Citigroup dropped their target price on shares of Teladoc Health from $11.00 to $8.75 and set a “neutral” rating on the stock in a research note on Friday, April 25th. Finally, Oppenheimer lowered their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $9.81.

Teladoc Health Stock Down 2.9 %

NYSE TDOC opened at $6.99 on Thursday. Teladoc Health has a 52 week low of $6.35 and a 52 week high of $15.21. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -1.21 and a beta of 1.73. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average of $8.10 and a two-hundred day moving average of $9.51.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.58% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. Point72 Asset Management L.P. increased its position in shares of Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after acquiring an additional 2,813,568 shares during the period. Renaissance Technologies LLC raised its stake in Teladoc Health by 15.5% in the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock worth $51,582,000 after acquiring an additional 763,265 shares during the last quarter. Geode Capital Management LLC lifted its position in Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after acquiring an additional 22,664 shares during the period. Finally, Maple Rock Capital Partners Inc. lifted its position in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.